Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin Therapy in Severe COPD
NCT07549932Completed
- Start
- Jan 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of atorvastatin in chronic obstructive pulmonary disease (COPD) (2 arms). Primary endpoints: Complete Blood Count at 6 months, Liver Function Tests at 6 months and 4 more. Started Jan 2024; status: completed.
02
Drugs
atorvastatin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07549932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07549932.